Literature DB >> 21160731

Aortic stenosis: An update.

Sangeetha Nathaniel1, Shreyas Saligram, Antony Leslie Innasimuthu.   

Abstract

Aortic stenosis (AS) is the most common valvular heart disease in the world. It is a disease of the elderly and as our population is getting older in both the developed and the developing world, there has been an increase in the prevalence of AS. It is impacting the mortality and morbidity of our elderly population. It is also causing a huge burden on the healthcare system. There has been tremendous progress in our understanding of AS in recent years. Lately, studies have shown that AS is not just a disease of the aortic valve but it affects the entire systemic vasculature. There are studies looking at more sophisticated measures of disease severity that might better predict the optimal timing of valve replacement. The improvement in our understanding in etiology and pathophysiology of the disease process has led to a number of trials with possible treatment options for AS. In this review, we talk about our understanding of the disease and latest developments in disease assessment and management. We look forward to a time when there will be medical treatment for AS.

Entities:  

Keywords:  Aortic stenosis; Diagnosis of aortic stenosis; Medical management of aortic stenosis; Valvular heart disease

Year:  2010        PMID: 21160731      PMCID: PMC2999052          DOI: 10.4330/wjc.v2.i6.135

Source DB:  PubMed          Journal:  World J Cardiol


  39 in total

Review 1.  Valvular aortic stenosis: disease severity and timing of intervention.

Authors:  Catherine M Otto
Journal:  J Am Coll Cardiol       Date:  2006-05-15       Impact factor: 24.094

2.  ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.

Authors:  Robert O Bonow; Blase A Carabello; Kanu Chatterjee; Antonio C de Leon; David P Faxon; Michael D Freed; William H Gaasch; Bruce Whitney Lytle; Rick A Nishimura; Patrick T O'Gara; Robert A O'Rourke; Catherine M Otto; Pravin M Shah; Jack S Shanewise; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel
Journal:  J Am Coll Cardiol       Date:  2006-08-01       Impact factor: 24.094

Review 3.  The year in valvular heart disease.

Authors:  Shahbudin H Rahimtoola
Journal:  J Am Coll Cardiol       Date:  2006-01-17       Impact factor: 24.094

4.  Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.

Authors:  Luis M Moura; Sandra F Ramos; José L Zamorano; Isabel M Barros; Luis F Azevedo; Francisco Rocha-Gonçalves; Nalini M Rajamannan
Journal:  J Am Coll Cardiol       Date:  2007-01-22       Impact factor: 24.094

5.  Bone formation and inflammation in cardiac valves.

Authors:  E R Mohler; F Gannon; C Reynolds; R Zimmerman; M G Keane; F S Kaplan
Journal:  Circulation       Date:  2001-03-20       Impact factor: 29.690

6.  Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves.

Authors:  M Olsson; J Thyberg; J Nilsson
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-05       Impact factor: 8.311

7.  Human aortic valve calcification is associated with an osteoblast phenotype.

Authors:  Nalini M Rajamannan; Malayannan Subramaniam; David Rickard; Stuart R Stock; Janis Donovan; Margaret Springett; Thomas Orszulak; David A Fullerton; A J Tajik; Robert O Bonow; Thomas Spelsberg
Journal:  Circulation       Date:  2003-04-28       Impact factor: 29.690

8.  C-reactive protein is increased in patients with degenerative aortic valvular stenosis.

Authors:  A Galante; A Pietroiusti; M Vellini; P Piccolo; G Possati; M De Bonis; R L Grillo; C Fontana; C Favalli
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

9.  Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis.

Authors:  K D O'Brien; D D Reichenbach; S M Marcovina; J Kuusisto; C E Alpers; C M Otto
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-04       Impact factor: 8.311

10.  Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial.

Authors:  Kwan Leung Chan; Koon Teo; Jean G Dumesnil; Andy Ni; James Tam
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

View more
  8 in total

Review 1.  One problem two issues! Left ventricular systolic and diastolic dysfunction in aortic stenosis.

Authors:  Maqsood M Elahi; Anthony Chuang; Michael J Ewing; Charles H Choi; Peter W Grant; Bashir M Matata
Journal:  Ann Transl Med       Date:  2014-01

2.  Patient prosthesis mismatch and its impact on left ventricular regression following aortic valve replacement in aortic stenosis patients.

Authors:  Abid Iqbal; Varghese Thomas Panicker; Jayakumar Karunakaran
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2018-08-28

Review 3.  Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Systematic Review of Non-Invasive Ways of Risk Stratification, Especially in Patients Undergoing Transcatheter Aortic Valve Replacement.

Authors:  Elke Boxhammer; Alexander E Berezin; Vera Paar; Nina Bacher; Albert Topf; Sergii Pavlov; Uta C Hoppe; Michael Lichtenauer
Journal:  J Pers Med       Date:  2022-04-08

4.  Comparison of goal-directed hemodynamic optimization using pulmonary artery catheter and transpulmonary thermodilution in combined valve repair: a randomized clinical trial.

Authors:  Andrey I Lenkin; Mikhail Y Kirov; Vsevolod V Kuzkov; Konstantin V Paromov; Alexey A Smetkin; Mons Lie; Lars J Bjertnæs
Journal:  Crit Care Res Pract       Date:  2012-04-30

5.  Screening Tool to Identify Patients with Advanced Aortic Valve Stenosis.

Authors:  Sameh Yousef; Andrea Amabile; Chirag Ram; Huang Huang; Varun Korutla; Saket Singh; Ritu Agarwal; Roland Assi; Rita K Milewski; Yawei Zhang; Prakash A Patel; Markus Krane; Arnar Geirsson; Prashanth Vallabhajosyula
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

6.  Impact of patient-prosthesis mismatch on 30-day outcomes in young and middle-aged patients undergoing aortic valve replacement.

Authors:  Daniel Hernández-Vaquero; Juan C Llosa; Rocío Díaz; Zain Khalpey; Carlos Morales; Rubén Álvarez; Jose López; Francisco Boye
Journal:  J Cardiothorac Surg       Date:  2012-05-15       Impact factor: 1.637

7.  Anesthetic management of a patient with obstructive prosthetic aortic valve dysfunction: a case report.

Authors:  Bo Ra Lee; Jeong-Rim Lee; Min Soo Kim
Journal:  Korean J Anesthesiol       Date:  2014-02-28

8.  Glasgow Prognostic Score as a Marker of Mortality after TAVI.

Authors:  Ozge Ozcan Abacioglu; Nermin Yildiz Koyunsever; Salih Kilic; Arafat Yildirim; Ibrahim Halil Kurt
Journal:  Braz J Cardiovasc Surg       Date:  2021-12-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.